Sepsis remains one of the major challenges in critical care, and the rapid and reliable identification of causative pathogens continues to be difficult.
This webinar explores the potential of metagenomic next-generation sequencing (mNGS) to advance pathogen identification in patients with sepsis and septic shock. It traces the development of mNGS from early proof-of-concept studies to the multicenter, randomized DigiSep trial.
The webinar compares mNGS with conventional blood culture diagnostics and presents key findings from DigiSep. Beyond pathogen detection, the webinar also focuses on a critical question: How can diagnostic findings be translated into meaningful clinical actions?
Register now to gain valuable insights into the clinical potential of mNGS and the key lessons learned from the DigiSep trial.
Key Learning Objectives
- Gain an understanding of the principle of mNGS in sepsis diagnostics
- Learn how mNGS compares with conventional blood culture
- Understand the design and key findings of the DigiSep trial
- Recognize the importance of translating mNGS results into treatment decisions
Register
